Merck Capital Ventures
Merck is a research-intensive biopharmaceutical company committed to improving health and well-being worldwide through innovative medicines, vaccines, and health solutions. With a history spanning over 130 years, Merck operates responsibly and strives to be a leader in scientific discovery, patient care, and sustainability. The company actively collaborates with biotech and research organizations globally to advance drug discovery and development, including partnerships in oncology, neurology, autoimmune diseases, and infectious diseases.
Industries
Nr. of Employees
Very Large (1000+)
Merck Capital Ventures
Woodcliff Lake, New Jersey, United States, North America
Services
Research collaborations and licensing
Partnered discovery and development programs including joint research, licensing agreements and co-funded development activities.
Clinical-trial management and support
Support and execution of clinical studies, trial recruitment resources and patient-facing trial information.
AI and data-science enabled discovery services
Application of data science, machine learning and generative AI approaches via internal programs and external collaborations to identify and assess drug targets and candidates.
Manufacturing support for clinical development
Support, funding and operational activities for manufacturing clinical-supply products, including early-phase allogeneic cell therapy manufacturing through Phase 1 in collaborative programs.
Enzyme engineering and biocatalysis collaborations
Collaborative engineering of enzymes for use as biocatalysts to improve API manufacturing efficiency and sustainability.
Oral peptide formulation development (collaborative)
Co-development and licensing support for oral peptide delivery technologies and formulation optimization.
Research collaborations and licensing
Partnered discovery and development programs including joint research, licensing agreements and co-funded development activities.
Clinical-trial management and support
Support and execution of clinical studies, trial recruitment resources and patient-facing trial information.
AI and data-science enabled discovery services
Application of data science, machine learning and generative AI approaches via internal programs and external collaborations to identify and assess drug targets and candidates.
Manufacturing support for clinical development
Support, funding and operational activities for manufacturing clinical-supply products, including early-phase allogeneic cell therapy manufacturing through Phase 1 in collaborative programs.
Enzyme engineering and biocatalysis collaborations
Collaborative engineering of enzymes for use as biocatalysts to improve API manufacturing efficiency and sustainability.
Oral peptide formulation development (collaborative)
Co-development and licensing support for oral peptide delivery technologies and formulation optimization.
Expertise Areas
- Clinical trial management
- Diversity in clinical research
- Business development and licensing
- AI- and ML-driven drug discovery
Key Technologies
- Machine learning and generative AI for drug discovery
- Synthetic biology for therapeutic proteins and biocatalysis
- Next-generation sequencing and single-nucleus transcriptomics
- Oligonucleotide therapeutic platforms